ProShares Ultra Nasdaq Biotechnology (BIB) News Today $53.66 -5.31 (-9.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Decrease in Short InterestProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a significant drop in short interest in the month of October. As of October 31st, there was short interest totalling 7,600 shares, a drop of 54.8% from the October 15th total of 16,800 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is presently 0.7 days.November 13, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Below 50-Day Moving Average - Here's WhyProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below Fifty Day Moving Average - Should You Sell?November 6, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest UpdateProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 16,800 shares, an increase of 100.0% from the September 30th total of 8,400 shares. Based on an average trading volume of 12,300 shares, the short-interest ratio is presently 1.4 days.October 26, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 5.4%ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 8,700 shares, a decline of 5.4% from the August 15th total of 9,200 shares. Based on an average daily trading volume, of 13,900 shares, the short-interest ratio is presently 0.6 days.September 18, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechn (^BIB-IV)September 16, 2024 | ca.finance.yahoo.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Pass Above 50-Day Moving Average of $64.82ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Pass Above 50 Day Moving Average of $64.82September 13, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below 50 Day Moving Average of $64.12ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Below 50 Day Moving Average of $64.12September 5, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving Average of $62.42ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above Fifty Day Moving Average of $62.42August 22, 2024 | marketbeat.comProShares Ultra Nasdaq BiotechnologyAugust 20, 2024 | morningstar.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Drops By 35.0%ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 5,200 shares, a decline of 35.0% from the July 15th total of 8,000 shares. Based on an average trading volume of 17,200 shares, the days-to-cover ratio is currently 0.3 days.August 14, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average of $60.85ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50 Day Moving Average of $60.85August 2, 2024 | marketbeat.comBio-Techne backs Harvard spinout making 'ultra-sensitive' blood testing techJuly 30, 2024 | bizjournals.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 220.0% in JulyProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 8,000 shares, a growth of 220.0% from the June 30th total of 2,500 shares. Based on an average trading volume of 18,300 shares, the short-interest ratio is currently 0.4 days.July 25, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Decline in Short InterestProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 2,500 shares, a decline of 39.0% from the June 15th total of 4,100 shares. Based on an average trading volume of 19,500 shares, the short-interest ratio is currently 0.1 days.July 12, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Above Fifty Day Moving Average of $57.71ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Pass Above 50 Day Moving Average of $57.71July 11, 2024 | marketbeat.comToth Financial Advisory Corp Grows Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)Toth Financial Advisory Corp grew its stake in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Free Report) by 132.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 26,111 shares of the exchange traded fund's stock afterJune 30, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Decreases By 26.8%ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 4,100 shares, a decrease of 26.8% from the May 31st total of 5,600 shares. Based on an average daily trading volume, of 28,100 shares, the short-interest ratio is currently 0.1 days.June 29, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Increases Dividend to $0.26 Per ShareProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) declared a quarterly dividend on Tuesday, June 25th. Investors of record on Wednesday, June 26th will be given a dividend of 0.2648 per share by the exchange traded fund on Wednesday, July 3rd. This represents a $1.06 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date of this dividend is Wednesday, June 26th. This is a positive change from ProShares Ultra Nasdaq Biotechnology's previous quarterly dividend of $0.04.June 26, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Significant Decline in Short InterestProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 5,600 shares, a decline of 53.7% from the May 15th total of 12,100 shares. Based on an average trading volume of 28,700 shares, the days-to-cover ratio is currently 0.2 days.June 13, 2024 | marketbeat.comCassaday & Co Wealth Management LLC Has $257,000 Holdings in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)Cassaday & Co Wealth Management LLC reduced its holdings in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Free Report) by 86.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,499 shares of the exJune 9, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Above 50 Day Moving Average of $54.20ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Above 50-Day Moving Average of $54.20June 7, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Drops By 25.3%ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 12,100 shares, a decrease of 25.3% from the April 30th total of 16,200 shares. Based on an average daily trading volume, of 32,700 shares, the short-interest ratio is presently 0.4 days.May 30, 2024 | marketbeat.comCassaday & Co Wealth Management LLC Trims Stock Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)Cassaday & Co Wealth Management LLC cut its holdings in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Free Report) by 86.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,499 shares of the exchange trMay 22, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50-Day Moving Average of $54.17ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above Fifty Day Moving Average of $54.17May 22, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 56.3% in AprilProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 16,200 shares, a decline of 56.3% from the April 15th total of 37,100 shares. Based on an average daily volume of 34,200 shares, the short-interest ratio is currently 0.5 days.May 11, 2024 | marketbeat.comProShares Ultra Bloomberg Natural Gas: Trading Short-Term Tailwinds (Rating Upgrade)April 29, 2024 | seekingalpha.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Significant Growth in Short InterestProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 37,100 shares, an increase of 201.6% from the March 31st total of 12,300 shares. Based on an average daily volume of 39,300 shares, the short-interest ratio is presently 0.9 days.April 25, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declines By 77.9%ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 12,300 shares, a decline of 77.9% from the March 15th total of 55,700 shares. Based on an average daily volume of 41,500 shares, the short-interest ratio is presently 0.3 days.April 10, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 98.2% in MarchProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 55,700 shares, a growth of 98.2% from the February 29th total of 28,100 shares. Based on an average trading volume of 41,800 shares, the days-to-cover ratio is currently 1.3 days.March 28, 2024 | marketbeat.comWall Street's Favorite Biotech Stocks? 3 Names That Could Make You Filthy RichMarch 25, 2024 | investorplace.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0403March 22, 2024 | msn.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Plans Dividend of $0.04ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) announced a dividend on Tuesday, March 19th. Stockholders of record on Thursday, March 21st will be paid a dividend of 0.0403 per share by the exchange traded fund on Wednesday, March 27th. The ex-dividend date is Wednesday, March 20th.March 20, 2024 | marketbeat.comShort Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Rises By 53.6%ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 29th, there was short interest totalling 28,100 shares, a growth of 53.6% from the February 14th total of 18,300 shares. Based on an average daily volume of 37,800 shares, the short-interest ratio is currently 0.7 days.March 14, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average of $58.27ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Pass Above Fifty Day Moving Average of $58.27March 8, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above Fifty Day Moving Average of $57.97ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Pass Above Fifty Day Moving Average of $57.97February 29, 2024 | marketbeat.com3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024February 22, 2024 | investorplace.comProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below 50 Day Moving Average of $57.16ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Pass Below Fifty Day Moving Average of $57.16February 21, 2024 | marketbeat.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0383December 20, 2023 | msn.com5 Most Promising Biotech Stocks to Buy According to AnalystsDecember 15, 2023 | insidermonkey.comBIB ETF Stock Price HistoryOctober 29, 2023 | investing.comProShares Trust - ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)June 18, 2023 | fool.comBIB - ProShares Ultra Nasdaq BiotechnologyMay 30, 2023 | finance.yahoo.comNeedham Reiterates Rocket Pharmaceuticals (RCKT) Buy RecommendationApril 20, 2023 | msn.comChardan Capital Maintains Immuneering Corp (IMRX) Buy RecommendationApril 20, 2023 | msn.comEF Hutton Reiterates Adaptimmune Therapeutics (ADAP) Buy RecommendationApril 11, 2023 | msn.comWedbush Initiates Coverage of Janux Therapeutics (JANX) with Outperform RecommendationApril 7, 2023 | msn.comCitigroup Maintains Applied Therapeutics (APLT) Buy RecommendationApril 5, 2023 | msn.comToth Financial Advisory Corp Has $979,000 Position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)Toth Financial Advisory Corp lifted its holdings in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Get Rating) by 125.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,971 sharApril 2, 2023 | marketbeat.comProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.0198December 23, 2022 | msn.comBiotech ETFs rally in Q4 fueled by 70%+ surge in ModernaDecember 22, 2022 | msn.com Get ProShares Ultra Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… BIB Media Mentions By Week BIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIB News Sentiment▼1.560.93▲Average News Sentiment BIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIB Articles This Week▼30▲BIB Articles Average Week Get ProShares Ultra Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Invesco Nasdaq Biotechnology ETF News ProShares UltraShort Nasdaq Biotechnology News Invesco S&P SmallCap Health Care ETF News VanEck Pharmaceutical ETF News iShares Biotechnology ETF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
